AT
Atrium Therapeutics, Inc. Common Stock
🇺🇸XNAS.RNAUnited StatesHealthcare
$9.97USDdown -0.24 (-2.35%)OpenEnd of day3:29 PM
Price$9.97-0.24 (-2.35%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US04965N1046
- CUSIP
- N71546100
Company
- Employees
- 511
- Headquarters
- San Diego, United States
- CEO
- Ms. Kathleen P. Gallagher
Market
- Shares outstanding
- 17.1M
- Market cap
- $170.54M
Highlights
- Market cap
- $170.54M
- EPS LTM
- -$5.45calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.83calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $35.97M+235.29%up year on year
- Net income
- -$93.18M+79.56%up year on year
- Gross margin
- 94.47%+107.87%up year on year
- Free cash flow
- -$217.39M+56.75%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.